Finance

Lists
Why is PTX down 3,03%?
Dive Deeper
PTX:ASX
Prescient Therapeutics Ltd
0,064 AUD
-3,03%
(-0,0020) 1D
5 ოქტ, 16:00:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PTX...
Open
0,07 AUD
High
0,07 AUD
Low
0,06 AUD
Mkt. cap
69,02 მლნ.
Avg. vol.
1,19 მლნ.
Volume
245,97 ათ.
52-wk high
0,12 AUD
52-wk low
0,04 AUD
EPS
-0,01 AUD
Shares outstanding
1,14 მლრდ.
No. of employees
3
Open
0,07 AUD
High
0,07 AUD
Low
0,06 AUD
Mkt. cap
69,02 მლნ.
Avg. vol.
1,19 მლნ.
Volume
245,97 ათ.
52-wk high
0,12 AUD
52-wk low
0,04 AUD
EPS
-0,01 AUD
Shares outstanding
1,14 მლრდ.
No. of employees
3
News stories
From web sources and news partners
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOსტივენ იატომი-კლარკ
Employees3
Founded22 მაი. 1986
Headquarters-
Sector-
Websiteptxtherapeutics.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
578,89 ათ.
578,89 ათ.
1,15 მლნ.
1,15 მლნ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,24 მლნ.
1,24 მლნ.
1,40 მლნ.
1,40 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,13 მლნ.
1,13 მლნ.
1,20 მლნ.
1,20 მლნ.
Operating expense
2,57 მლნ.
2,57 მლნ.
2,73 მლნ.
2,73 მლნ.
Total operating expenses
2,57 მლნ.
2,57 მლნ.
2,73 მლნ.
2,73 მლნ.
Operating income
-1,99 მლნ.
-1,99 მლნ.
-1,58 მლნ.
-1,58 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-1,99 მლნ.
-1,99 მლნ.
-1,51 მლნ.
-1,51 მლნ.
EBT excluding unusual items
-1,99 მლნ.
-1,99 მლნ.
-1,51 მლნ.
-1,51 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,99 მლნ.
-1,99 მლნ.
-1,51 მლნ.
-1,51 მლნ.
Net profit margin
-344,35%
-344,35%
-131,51%
-131,51%
Earnings per share
-
-
-
-
Interest and investment income
1,86 ათ.
1,86 ათ.
67,39 ათ.
67,39 ათ.
Interest expense
-2,97 ათ.
-2,97 ათ.
-2,38 ათ.
-2,38 ათ.
Net interest expenses
-1,12 ათ.
-1,12 ათ.
65,02 ათ.
65,02 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-1,55 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები